ARTICLE | Distillery Therapeutics
Cancer
June 7, 2017 3:54 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting MBNL3 could help treat hepatocellular carcinoma (HCC) and other liver cancers. In tissue samples from HCC patients, levels of MBNL3 we...
BCIQ Company Profiles
BCIQ Target Profiles